RINGER LACTATE INJECTION 500ML

IndicationsRinger Lactate Injection is indicated as a source of water and electrolytes or as an alkalinizing agent.Dosage and AdministrationDosage:As directed by a veterinarian. Dosage is dependent up

  • Product No.: AMC41033-02
  • Specification: 500ML
  • Trademark: Boomvet
  • Support OEM/ODM: Yes
  • Mini. Order: 10000Bottles
  • Delivery Time: 30~60 Days
  • Trade Term: FOB,CIF
  • Payment Term: T/T,L/C
  • Standard Available: CP,BP
  • Documents: GMP,COPP,CTD

Indications

Ringer Lactate Injection is indicated as a source of water and electrolytes or as an alkalinizing agent.

Dosage and Administration

Dosage:

As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.

Usage:

Intravenous Injection

Precautions&warning:

1. Do not administer to horses by intraperitoneal injection.

2. Ringer Lactate Injection should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.

3. Ringer Lactate Injection should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.

4. Ringer Lactate Injection should be used with great care in patients with metabolic or respiratory alkalosis. The administration of lactate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.

5. Ringer Lactate Injection should not be administered simultaneously with blood through the same administration set because of the likelihood of coagulation.

6. The parenteral administration of Ringer Lactate Injection can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.

7. In patients with diminished renal function, administration of Ringer Lactate Injection may result in sodium or potassium retention.

8. Ringer Lactate Injection is not for use in the treatment of lactic acidosis.

Adverse reaction:

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.

Precautions:

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation. Ringer Lactate Injection must be used with caution. Excess administration may result in metabolic alkalosis. Caution must be exercised in the administration of Ringer Lactate Injection to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear and seal is intact.

Storage instructions:

It is recommended the product be stored in the moisture overwrap at room temperature (25ºC/77ºF), Avoid excessive heat.